Evaluating the results of Nocturnal Penile Tumescence test utilizing Iranian erection analyzer - a case control study
Men's Health Journal,
Vol. 8 No. 1 (2024),
31 July 2024
,
Page e1
https://doi.org/10.22037/mhj.v8i1.44225
Abstract
Background: Erectile dysfunction (ED) is a male sexual condition that affects 10% to 25% of men globally. Identifying the underlying cause of ED in males is a critical aspect of diagnosis. For many years, the Rigiscan® devices have been utilized to distinguish between psychological and physiological erectile dysfunction. The purpose of this study was to look at the validity of an Iranian erection analyzer equipment for evaluating nocturnal penile tumescence (NPT) in ED patients referred to Shahada-e-Tajrish Hospital in 2021. Materials and Methods: Patients who were diagnosed with vascular erectile dysfunction by doppler ultrasound evaluation and intra-cavernosal injection (ICI) test were included in this study. Also, a group of sexually healthy volunteers were included in the study as a control group. After receiving written informed consent, both groups were evaluated for two nights with the NPT test with the Iranian Erection Analyzer device. The results of the two groups were collected and analyzed. Results: A total of 45 patients with erectile dysfunction and 29 sexually healthy individuals were included in the study. Both groups were hospitalized for two nights in the isolation room of the urology ward and the NPT test was performed for them. Our results showed that the NPT test performed by the Iranian Erection Analyzer device with 62% sensitivity and 100% specificity is capable of distinguishing patients with erectile dysfunction from sexually healthy men. Conclusions: Based on our results, the Iranian Erection Analyzer device is accurate enough to diagnose patients with erectile dysfunction and can be used in clinics.
- Erectile dysfunction
- Erection.
- Male Impotence
- Penile Tumescence
How to Cite
References
Zhang Y, Zhang Z, Zhang N. Role of RigiScan parameters in differentiation of vascular erectile dysfunction. Andrologia. 2020;52(10):e13620.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of urology. 1994;151(1):54-61.
Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. The journal of sexual medicine. 2009;6(10):2746-60.
Salonia A, Castagna G, Saccà A, Ferrari M, Capitanio U, Castiglione F, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function—Erectile function domain. The journal of sexual medicine. 2012;9(10):2708-15.
Wylie K, Davies-South D, Steward D, Walters S, Iqbal M, Ryles S. A comparison between portable ultrasound (MIDUS) and nocturnal RigiScan when confirming the diagnosis of vascular organic erectile disorder. International journal of impotence research. 2006;18(4):354-8.
SAFARINEZHAD M, FAIIAZ F. SCIENTIFIC VALUE OF DUPLEX DOPPLER ULTRASONOGRAPHY, NOCTURNAL PENILE TUMESCENCE (NPT), CAVERNOSOGRAPHY AND DYNAMIC CAVERNOSOMETRY IN DIAGNOSIS OF ERECTILE DYSFUNCTIONS. 2005.
Alinejad Khorram A, Razzaghi Z, Rahnama H, Allameh F. Normal Variations in Episodes and Duration of Nocturnal Penile Tumescence Among Iranian Men: A Descriptive Analytical Study. Nephro-Urol Mon. 2024;16(3):e146347. https://doi.org/10.5812/numonthly-146347.
Karadeniz T, Topsakal M, Aydogmus A, Beksan M. Role of RigiScan in the etiologic differential diagnosis of erectile dysfunction. Urologia internationalis. 1997;59(1):41-5.
HATZICHRISTOU DG, HATZIMOURATIDIS K, IOANNIDES E, YANNAKOYORGOS K, DIMITRIADIS G, KALINDERIS A. Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. The Journal of urology. 1998;159(6):1921-6.
Benet AE, Rehman J, Holcomb RG, Melman A. The correlation between the new RigiScan plus software and the final diagnosis in the evaluation of erectile dysfunction. The Journal of urology. 1996;156(6):1947-50.
Licht MR, Lewis RW, Wollan PC, Harris CD. Comparison of RigiScan and sleep laboratory nocturnal penile tumescence in the diagnosis of organic impotence. The Journal of urology. 1995;154(5):1740-3.
Weinberg JJ, Badlani GH. Utility of RigiScan and papaverine in diagnosis of erectile impotence. Urology. 1988;31(6):526-9.
Greenstein A, Chen J, Salonia A, Sofer M, Matzkin H, Montorsi F. Does Sildenafil Enhance Quality of Nocturnal Erections in Healthy Young Men? A NPT‐RigiScan™ Study. The Journal of Sexual Medicine. 2004;1(3):314-7.
Nagao K, Tai T, Iwai H, Kobayashi H, Nakajima K. AB020. Usefulness of RigiScan® evaluation of nocturnal penile tumescence. Translational Andrology and Urology. 2017;6(Suppl 3):AB020-AB.
Jannini EA, Granata AM, Hatzimouratidis K, Goldstein I. Controversies in sexual medicine: use and abuse of rigiscan in the diagnosis of erectile dysfunction. The journal of sexual medicine. 2009;6(7):1820-9.
Chen J, Greenstein A, Sofer M, Matzkin H. Rigiscan versus snap gauge band measurements: Is the extra cost justifiable? International journal of impotence research. 1999;11(6):315-8.
Wang T, Zhuan L, Liu Z, Li M-C, Yang J, Wang S-G, et al. Audiovisual sexual stimulation and RigiScan test for the diagnosis of erectile dysfunction. Chinese medical journal. 2018;131(12):1465-71.
Edgar R, Trip EJ, Wolterink GJ, Veltink PH, Beck JJ. New methods for the monitoring of nocturnal erections. International Journal of Impotence Research. 2022;34(1):1-7.
- Abstract Viewed: 61 times
- pdf Downloaded: 57 times